Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006401 · ClinicalTrials.gov registry record · Phase 3
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
A Phase 3 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 3
- Development phase
- 793
- Enrollment target
NCT00006401 is a Phase 3 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 793 participants.
The verdict
NCT00006401, a Phase 3 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 793 participants
- Enrollment target
Study Summary
To determine whether or not inhaled nitric oxide (iNO) safely decreases the incidence of chronic lung disease (CLD) in premature infants.
Interventions
- OTHER Placebo
- DRUG iNO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 793 participants |
| Start Date | 2000-09 |
| Est. Completion | 2007-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006401
The ClinicalTrials.gov registry entry for NCT00006401 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 793 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00006401 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006401 about?
NCT00006401 is a clinical study titled "Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants". To determine whether or not inhaled nitric oxide (iNO) safely decreases the incidence of chronic lung disease (CLD) in premature infants.
What is the current status of trial NCT00006401?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 793 participants. The study started on 2000-09. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00006401?
The interventions under investigation include: Placebo (OTHER), iNO (DRUG).
Who is sponsoring clinical trial NCT00006401?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.